The company’s upsized offering is a hopeful sign for venture investors in the sector.

Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a ...

CeriBell (NASDAQ:CBLL) shares rallied 35% Friday following the medical device maker’s $180M initial public offering. Shares ...

CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 ...

Ceribell Inc. launched its initial public offering of more than 10.6 million shares of common stock at $17 and steadily saw ...

Ceribell shares were higher in their Nasdaq debut after an upsized initial public offering priced at the high end of a projected range. Shares of Ceribell, maker of an AI-powered brain monitoring ...

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported ...

Three U.S. healthcare startups priced their initial public offerings (IPO) on Thursday, including Upstream Bio which raised ...

Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.

Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.